Trials / Unknown
UnknownNCT04714489
Public Title：A Study on the Registration of The Use of Feilike HeJi in Adults
Scientific Title：A Study on the Registration of The Use of Feilike HeJi in Adults
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Feilike HeJi is produced by Guizhou Jianxing Pharmaceutical Co. LTD. For the treatment of phlegm heat caused by lung cough phlegm yellow, bronchial asthma, bronchitis, see the syndrome of proprietary Chinese medicine (approval number: Z20025136) approved by the state and the drug from radix scutellariae, radix peucedani, radix stemonae, red gentian root of deal, phoenix tree, spreading hedyotis herb, red tube 7 flavour, with qingrejiedu, antitussive expectorant effect. In order to fully understand the safety of Feilike HeJi in clinical practice and fulfill the responsibility of production enterprises for patients, the production enterprises initiated this study to further evaluate the safety and understanding of the function characteristics of Feilike HeJi in a wide range of people, so as to guide the clinical rational drug use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NO. | NO. |
Timeline
- Start date
- 2021-01-16
- Primary completion
- 2021-06-01
- Completion
- 2021-08-01
- First posted
- 2021-01-19
- Last updated
- 2021-06-28
Locations
25 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04714489. Inclusion in this directory is not an endorsement.